期刊文献+

Ⅱ期结肠癌根治术淋巴结检取影响因素及预后价值分析 被引量:8

Affecting factors of lymph nodes retrieved number and prognostic value in stage Ⅱ colon cancer after radical surgery
原文传递
导出
摘要 目的:探讨Ⅱ期结肠癌根治术淋巴结检取的影响因素及预后价值。方法:收集2000-01-05-2009-12-31中国医科大学附属第四医院胃肠外科手术治疗且未经辅助治疗的Ⅱ期结肠癌患者216例,回顾性分析淋巴结检出数量与临床病理学特征的关系,采用单因素、多因素Cox比例风险模型和Kaplan-Meier法进行生存分析。结果:2000-01-2009-12淋巴结检出≥12个的比例从8.0%提高到91.7%。结肠癌淋巴结检出≥12个的患者2005-2009年手术者多于2000-2004年手术者,右半结肠癌多于左半结肠癌,肿瘤直径≥5cm多于<5cm者,T4a^T4b期多于T3期。淋巴结检出数量与手术年代(χ2=45.188,P<0.001)、肿瘤部位(χ2=5.413,P=0.020)、肿瘤大小(χ2=4.021,P=0.045)及T分期(χ2=8.533,P=0.014)明显相关,而与性别、年龄、病理类型、分化及术前CEA水平无明显相关。单因素分析显示,肿瘤大小(χ2=5.099,P=0.035)、术前CEA水平(χ2=4.244,P=0.043)、淋巴结检出数量(χ2=9.875,P=0.002)及T分期(χ2=8.012,P=0.008)是Ⅱ期结肠癌患者的预后因素。多因素分析显示,淋巴结检出数量(P=0.017)和T分期(P=0.044)是影响Ⅱ期结肠癌患者的独立预后因素。淋巴结检出≥12个的患者生存时间明显长于淋巴结检出<12个的患者生存时间,P=0.002。结论:手术年代、肿瘤部位,肿瘤大小及T分期是结肠癌根治术淋巴结检出数量的重要影响因素。淋巴结检出数量是Ⅱ期结肠癌患者生存重要的独立预后因素,因此结肠癌根治术中检取足够的淋巴结有利于合理评估预后。 OBJECTIVE:To investigate affecting factors the number of lymph nodes(LNs) retrieved and prognostic value in stage Ⅱcolon cancer after radical surgery. METHODS: The clinicopathologic data were collected from 216 pa tients with stageⅡ colon cancer treated with curative surgery alone at the Department of Gastrointestinal Surgery,Fourth Affiliated Hospital,China Medical University from January 5th, 2000 to December 31st, 2009. The relationship between the number of LNs retrieved and clinicopathologic features was retrospectively analyzed. The univariate and multivariate Cox proportional hazard model and Kaplan-Meier method were used to analyze the prognosis and influencing factors. RE- SULTS: From 2000-01 to 2009-12 ,the proportion of individuals who had 12 or more LNs retrieved during a colectomy for stage Ⅱ colon cancer increased from 8.0% to 91.7G. The number of patients who had ≥12 LNs retrieved in 2005-2009 in right colon cancer,tumor size ≥5 cm and stage T4a- T4b were more than that of 2000-2004, left colon cancer, tumor size ≥5 cm and stage T3. Having ≥12 LNs retrieved had a significant correlation with operative period (X2 =45. 188,P〈 0. 001) ,tumor site (X2=5. 413,P=0. 020) ,tumor size (X2 =4. 021,P=0. 045) and T stage (X2 =8. 533,P=0. 014) but no significant correlation with gender, age, pathology, differentiation and preoperative CEA levels. Univariate prognostic a nalysis showed that tumor size (Xz =5. 099,P=0. 035) ,preoperative CEA levels (X2 =4. 244,P=0. 043) ,the number of LNs retrieved (X2 = 9. 875,P=0. 002) and T stage (X2 = 8. 012,P= 0. 008) were prognostic factors in stage R colon cancer. Multivariable Cox's proportional hazard model analysis showed that the number of LNs retrieved (P = 0. 017)and T stage(P=0. 044)were independent prognostic factors in stage Ⅱ colon cancer. Media survival of having ≥12 LNsretrieved was obviously higher than that of having%12 LNs retrieved (P=0. 002) in stage 1I colorectal cancer. CONCLU- SIONS= There is a significant correlation between having 12 LNs retrieved and operative period, tumor site, tumor size and stage. The number of LNs retrieved is the most important independent prognostic factors for survival of patients in stage Ⅱ colon cancer. Satisfied LNs resection in colon cancer radical surgery is beneficial for prognosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第4期296-299,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 Ⅱ期结肠肿瘤 淋巴结 淋巴结检出数目 预后 colon neoplasms lymph nodes number of lymph nodes harvested prognosis
  • 相关文献

参考文献15

  • 1Chen SI., Bilchik AJ. More extensive nodal dissection improves survival for stages Ⅰ to Ⅲ of colon caneer: a population-based study[J]. Ann Surg,2006,244(4) :602-610.
  • 2Fan L, Levy M, Aguilar CE, et al. Lymph node retrieval from eolorec- tal resection specimens for adenocareinoma:is it worth the extra ef- fort to find at least 12 nodes[J]. Colorectal Dis, 2011,13 (12) : 1377- 1383.
  • 3Nelson H,Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery [J]. J Natl Cancer Inst,2001,93(8): 583-596.
  • 4Storli K,Sondenaa K,Furnes B,et al. Improved lymph node har vest from resected colon cancer specimens did not cause upsta ging fromTNM stage Ⅱ to Ⅲ[J].World J Surg,2011,35(12) 2796-2803.
  • 5Stoeehi L, Fazio VW, Lavery I, et al. Individual surgeon, patholo gist,and other factors affecting lymph node harvest in stage Ⅱ colon carcinoma, is a minimum of 12 examined lymph nodes suffi eient[J]. Ann Surg Oneol,2011,18(2) :405-412.
  • 6Chen H H, Chakravarty KD, Wang JY, et al. Pathological exami nation of 12 regional lymph nodes and long term survival in sta ges Ⅰ-Ⅲ colon cancer patients: an analysis of 2,056 consecu rive patients in two branches of same institution[J]. Int J Color eetal Dis,2010,25(11) :1333-1341.
  • 7Morikawa T, Tanaka N. Kuchiba A, et al. Predictors of lymph node count in colorectal cancer resections., data from US nation- wide prospective cohort studies[J]. Arch Surg, 2012, 147 (8) : 715-723.
  • 8Kuo YH,Lee KF, Chin CC, et al. Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage Ⅲ colon eaneer[J]. Int J Colorectal Dis,2012,27(12):1625-1635.
  • 9Choi HK, Law WL, Poon JT. The optima[ number of lymph nodes examined in stage Ⅱ colorectaI cancer and its impact of on outcomes [J]. BMC Cancer, 2010,10 : 267.
  • 10Elferink MA, Siesling S, Visser O,et al. Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population~ based study in the Netherlands[J]. Ann Oncol,2011,22(1) : 110- 117.

二级参考文献22

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2Edler D,Ohrling K,Hallstrom M,et al.The number of analyzed lymph nodes-a prognostic factor in colorectal cancer.Acta Oncol,2007,46(7):975-981.
  • 3Tsai HL,Cheng KI,Lu CY,et al.Prognostic significance of depth of invasion,vascular invasion and numbers of lymph node retrievals in combination for patients with stage Ⅱ coloreetal cancer undergoing radical resection.J Surg Oncol,2008,97(5):383-387.
  • 4Dillman RO,Aaron K,Heinemann FS,et al.Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.Cancer,2009,115(9):1840-1848.
  • 5Martínez-Ramos D,Escrig-Sos J,Miralles-Tena JM,et al.Is there a minimum number of lymph nodes that should be examined after surgical resection of colorectal cancer? Cir Esp,2008,83(3):108-117.
  • 6Vather R,Sammour T,Zargar-Shoshtari K,et al.Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer.Int J Colorectal Dis,2009,24(3):283-288.
  • 7Kim YW,Kim NK,Min BS,et al.The influence of the number of retrieved lymph nodes on staging and survival in patients with stage Ⅱ and Ⅲ rectal cancer undergoing tumorspecific mesorectal excision.Ann Surg,2009,249(6):965-972.
  • 8Yoshimatsu K,Ishibashi K,Umehara A,et al.How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.Hepatogastroenteroiogy,2005,52(66):1703-1706.
  • 9Cserni G,Vinh-Hung V,Burzykowski T.Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 coiorectal carcinomas? J Surg Oncol,2002,81(2):63-69.
  • 10Baxter NN,Virnig DJ,Rothenberger DA,et al.Lymph node evaluation in colorectal cancer patients:a population-based study.J Natl Cancer Inst,2005,97(3):219-225.

共引文献35

同被引文献73

  • 1朱亚东.乳腺癌术后无瘤生存率的影响因素及腋窝淋巴结检测数目的临床意义[J].实用癌症杂志,2014,29(2):222-225. 被引量:8
  • 2王继恒,李世荣.我国结直肠癌筛查和早期诊断十年回顾:1994~2005[J].胃肠病学,2006,11(4):245-250. 被引量:51
  • 3Valentini V. Van Stiphout RGPM, Lammer|ng G, et al. Nomo-grams for predicting local recurrence, distant metastases, and o-verall survival for patients with locally advanced rectal cancer onthe basis of European randomized clinical tfials[j]. J Clin Oncol,2011,29(23):3163-3172.
  • 4Sauer R,Liersch T,Merkel S,et al. Preoperative versus postop-erative chemoradiotherapy for locally advanced rectal cancer: re-sults of the German CAO/ARO/AIO-94 randomized phase 瓜trial after a median follow-up of 11 years[J]. J Clin Oncol,2012,30(16):1926-1933.
  • 5Walter V, Jansen L, Hoffmeister M, et al. Smoking and survivalof colorectal cancer patients : systematic review and meta-analysis[J]. Ann Oncol,2014,25(8) :1517-1525.
  • 6Nishihara R,Morikawa T,Kuchiba A,et al. A prospective studyof duration of smoking cessation and colorectal cancer risk by ep-igenetics-related tumor classification[j]. Am J Epidemiol,2013,178(1):84-100.
  • 7Zhong R,Liu L,Zou L,et al. Genetic variations in the TGFb sig-naling pathway f smoking and risk of colorectal cancer in a Chi-nese population[J]. Carcinogenesis,2013 ,34(4) : 936-942.
  • 8Samadder NJ. Vierkant RA,Tillmans LS,et al. Cigarette smok-ing and colorectal cancer risk by KRAS mutation status amongolder women[J]. Am J Gastroenterol, 2012 ,107(5) : 782-789.
  • 9Limsui D, Vierkant RA, Tillmans LS,et al. Cigarette smokingand colorectal cancer risk by molecularly defined subtypes[J]. JNatl Cancer Inst,2010,102(14) : 1012-1022.
  • 10Yi NY,Liu ESL,Shin VY,et al. The modulating role of nuclear factor-kB in the action of a7.nicotinic acetylcholine receptor and cross-talk be-tween 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth in-duced by 4-(N-methyl-N-nitrosamino)-l-(3-pyridyl)-l-butanone[J]. JPharmacol Exp Ther,2004,311(l) :123-130.

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部